These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 7199953

  • 1. [Factors of the fibrinolysis of the vascular wall in patients with different severity of atherosclerosis and of different age].
    Kovalenko AN.
    Biull Eksp Biol Med; 1982 Jan; 93(1):26-8. PubMed ID: 7199953
    [No Abstract] [Full Text] [Related]

  • 2. Measurement of endothelial fibrinolytic activity in aorta and vena cava in rabbits: a fibrin-agar plate method.
    Kamio A, Shiraishi M, Shitama K, Sugimoto Y, Honda K, Takebayashi S.
    Artery; 1979 Jan; 5(1):76-89. PubMed ID: 575477
    [Abstract] [Full Text] [Related]

  • 3. [Studies on fibrinolysis in patient with metastasizing malignancies and in patients with non-metastasizing brain tumors].
    Scharrer I, Hübner H.
    Verh Dtsch Ges Inn Med; 1979 Jan; 83():1144-8. PubMed ID: 611808
    [No Abstract] [Full Text] [Related]

  • 4. [Plasminogen, antiplasmins and the rate of fibrinolysis in hypertension and atherosclerosis].
    Gritsiuk AI.
    Kardiologiia; 1968 May; 8(5):54-8. PubMed ID: 5671692
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of angiotensin II on indices of the fibrinolysis system in experiments in vitro].
    Golubenkova NI.
    Lab Delo; 1981 May; (12):720-2. PubMed ID: 6172641
    [No Abstract] [Full Text] [Related]

  • 6. [Relations between fibrinolysis and human atherosclerosis. Tissue activator of plasminogen of the arterial wall].
    Tesi M, Caramelli L.
    Boll Soc Ital Cardiol; 1973 May; 18(2):181-94. PubMed ID: 4807057
    [No Abstract] [Full Text] [Related]

  • 7. Antifibrinolytic activity in middle ear effusion.
    Hamaguchi Y, Sakakura Y, Ukai K, Ohi M, Miyoshi Y.
    ORL J Otorhinolaryngol Relat Spec; 1984 May; 46(5):235-41. PubMed ID: 6237294
    [Abstract] [Full Text] [Related]

  • 8. [Fibrinolytic system in atherogenesis].
    Kołodziejczyk J, Nowak P.
    Postepy Biochem; 2004 May; 50(3):248-55. PubMed ID: 15822754
    [No Abstract] [Full Text] [Related]

  • 9. [Relation between the fibrinolytic activity of the blood, placenta and fetal membranes in normal and complicated pregnancy].
    Kuznik BI, Zagorodniaia ED, Khyshova DR.
    Akush Ginekol (Mosk); 1983 Oct; (10):14-6. PubMed ID: 6686414
    [No Abstract] [Full Text] [Related]

  • 10. Effect of venous stasis on vessel wall fibrinolysis.
    Stenberg B, Bylock A, Risberg B.
    Thromb Haemost; 1984 Apr 30; 51(2):240-2. PubMed ID: 6539959
    [Abstract] [Full Text] [Related]

  • 11. Decreased fibrinolytic activity in human atherosclerotic vessels.
    Ljungnér H, Bergqvist D.
    Atherosclerosis; 1984 Jan 30; 50(1):113-6. PubMed ID: 6538086
    [Abstract] [Full Text] [Related]

  • 12. [The state of the blood fibrinolytic system in rabbits with experimental atherosclerosis].
    Nikitin IuP, Tabarovskaia TA.
    Biull Eksp Biol Med; 1968 Nov 30; 66(11):20-2. PubMed ID: 5758116
    [No Abstract] [Full Text] [Related]

  • 13. [Fibrinolytic activity of the human aortic wall in arteriosclerosis].
    Andreenko GV, Nikitin IuP.
    Arkh Patol; 1968 Nov 30; 30(11):15-8. PubMed ID: 5733151
    [No Abstract] [Full Text] [Related]

  • 14. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL, Mathew P.
    Haemophilia; 2008 Nov 30; 14(6):1250-4. PubMed ID: 19141165
    [Abstract] [Full Text] [Related]

  • 15. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M.
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971 Nov 30; 16():159-90. PubMed ID: 5004447
    [No Abstract] [Full Text] [Related]

  • 16. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH, Rijken DC.
    Thromb Haemost; 2004 Mar 30; 91(3):473-9. PubMed ID: 14983222
    [Abstract] [Full Text] [Related]

  • 17. [Components of the fibrinolytic system of cadaveric blood in certain types of death].
    Krut' MI, Paradeeva IK.
    Probl Gematol Pereliv Krovi; 1976 Dec 30; 21(12):30-2. PubMed ID: 1024202
    [No Abstract] [Full Text] [Related]

  • 18. [Behavior of silica in blood serum and in the aortic walls of subjects of various ages in health and arteriosclerosis].
    Mars G, Nebbia ML, Nebuloni G, Necchi della Silva A.
    G Gerontol; 1970 Jul 30; 18(7):645-59. PubMed ID: 5533445
    [No Abstract] [Full Text] [Related]

  • 19. Management of penetrating juxtahepatic inferior vena cava injuries under total vascular occlusion.
    Khaneja SC, Pizzi WF, Barie PS, Ahmed N.
    J Am Coll Surg; 1997 May 30; 184(5):469-74. PubMed ID: 9145066
    [Abstract] [Full Text] [Related]

  • 20. [Tissue factors of blood coagulation in the atherosclerotic blood vessel wall].
    Al'fonsov VV, Kuznik BI.
    Probl Gematol Pereliv Krovi; 1966 Nov 30; 11(11):3-9. PubMed ID: 6001923
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.